NDC 71858-0010-04 - Tirosint
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71858-0010
- Requested NDC
- 71858-0010-04
- Package NDCs from labels
- 71858-0010-4, 71858-0010-1, 71858-0010-2, 71858-0010-04
- Manufacturer
- IBSA Pharma Inc.
- Effective date
- 2026-03-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tirosint - IBSA Pharma Inc. | IBSA Pharma Inc. | 2026-03-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71858-0010-1 | Tirosint | 1 in 1 CARTON | CAPSULE | 1 | 13 | |
| 71858-0010-1 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-2 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 | |
| 71858-0010-2 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71858-0010 | TIROSINT (LEVOTHYROXINE SODIUM) CAPSULE [IBSA PHARMA INC.] | 11 | Current NDC, Legacy NDC, 6 package rows | 20241027_7a7ade79-0165-4e31-b84e-667416c00c7e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71858-0010-4 | EA - Each | 71858-0010 | 8f761cf5-7112-4857-b7b7-8b5c293cc319 | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 27e98e6d-9fd7-3a94-e063-6394a90a1dcb | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 576dcd01-d151-42ac-acd1-480a13bae176 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 29bb8dbe-f8ba-e2ba-e063-6394a90af38c | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a0ffe111-3574-4481-a732-b68a7d58ef71 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a55e735f-a5b0-4b85-9fd7-3a4b6723a81b | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 893f9d10-7ce5-4ae6-8f03-dfde35ca6c30 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f23cacf6-0509-4e6b-bb59-6f1c17b16411 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 6edb9499-b869-4ec8-82d7-56d267fd3dec | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ee67e24-d72f-4419-a7d2-95bb44d9dd26 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | b57d0cc5-9fc7-496a-9bfa-417a288bb825 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 68a6702d-ca0b-4e04-88a6-4accc8fb459e | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Fendall Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | afda6fc3-7615-b0be-e053-2995a90a6208 | 2024-12-10 | Warnings | 059QF0KO0R |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e1f77539-2156-4890-baca-8b13779c745c | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.